ANDREW POE: Open Payments
NPI 1811412083 · SPRINGVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,235 in 67 payments from 16 companies in 2025. Trend: 2023 $332 · 2024 $976 · 2025 $1,235
Food & beverage: $1,235
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 10 | $213 |
| GlaxoSmithKline, LLC. | 11 | $201 |
| Paratek Pharmaceuticals, Inc. | 14 | $194 |
| AstraZeneca Pharmaceuticals LP | 7 | $144 |
| Exact Sciences Corporation | 5 | $91 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $82 |
| Sumitomo Pharma America, Inc. | 3 | $73 |
| Lundbeck LLC | 2 | $44 |
| ABBVIE INC. | 2 | $39 |
| Novo Nordisk Inc | 2 | $37 |
Products named: REXULTI, TRELEGY ELLIPTA, NUZYRA, CAPLYTA, GEMTESA, BREZTRI, Cologuard Collection Kit, AIRSUPRA.
Industry payments across AL — which companies pay providers there.
